| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 520 | 1.354 | 2.461 | 2.239 | 714 | 1.418 | 1.627 | 2.141 | 3.277 | 4.576 |
| Total Income - EUR | 520 | 1.354 | 2.461 | 2.239 | 714 | 1.418 | 1.627 | 2.141 | 3.277 | 4.584 |
| Total Expenses - EUR | 2.715 | 3.739 | 4.193 | 5.288 | 4.147 | 4.155 | 5.072 | 5.614 | 5.811 | 4.627 |
| Gross Profit/Loss - EUR | -2.195 | -2.385 | -1.733 | -3.049 | -3.432 | -2.737 | -3.445 | -3.472 | -2.533 | -43 |
| Net Profit/Loss - EUR | -2.211 | -2.426 | -1.807 | -3.116 | -3.454 | -2.764 | -3.445 | -3.472 | -2.533 | -71 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Perla Medident Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.793 | 2.323 | 1.863 | 3.337 | 2.648 | 1.984 | 1.340 | 834 | 594 | 354 |
| Current Assets | 311 | 491 | 761 | 462 | 906 | 1.170 | 918 | 848 | 1.250 | 1.847 |
| Inventories | 267 | 406 | 320 | 346 | 503 | 594 | 700 | 662 | 643 | 774 |
| Receivables | 0 | 0 | 0 | 0 | 151 | 148 | 145 | 145 | 145 | 166 |
| Cash | 44 | 85 | 441 | 115 | 252 | 428 | 73 | 41 | 463 | 907 |
| Shareholders Funds | -3.638 | -6.027 | -7.731 | -10.706 | -13.952 | -16.451 | -19.531 | -23.064 | -25.527 | -25.456 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.742 | 8.840 | 10.355 | 14.505 | 17.506 | 19.606 | 21.790 | 24.746 | 27.371 | 27.658 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Perla Medident Srl